Literature DB >> 18708951

Epidemiological, clinical, laboratory findings, and outcomes of disseminated tuberculosis in Tehran, Iran.

Mehrdad Hasibi1, Mehrnaz Rasoulinejad, Seyed-Mahmoud Eshagh Hosseini, Parastoo Davari, Azadeh Sahebian, Patricia Khashayar.   

Abstract

BACKGROUND: Disseminated tuberculosis (TB) accounts for 1 to 3% of all TB cases. This retrospective study reviews the clinical, radiological, laboratory findings and outcome in patients with disseminated tuberculosis in an endemic area.
METHODS: Medical records were reviewed for patients with disseminated TB admitted to two tertiary centers in Tehran, Iran between 1999 and 2006.
RESULTS: Fifty patients were found to have disseminated TB. A miliary pattern was documented in the chest x-ray of 34 patients. Hematologic abnormalities including anemia, leukopenia, and thrombocytopenia were frequently observed. Death occurred in nine of the cases. The mortality rate was significantly higher in diabetic patients, injection drug users, and patients with hematologic abnormalities; however, steroid usage and human immunodeficiency virus infection were not significantly associated with a higher mortality rate. Clinical improvement occurred in 41 patients following treatment.
CONCLUSION: Disseminated TB could have different manifestations. Hematologic abnormalities are common and are considered poor prognostic signs in these patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18708951     DOI: 10.1097/SMJ.0b013e318180bcfd

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  3 in total

1.  Lethal tuberculosis in a previously healthy adult with IL-12 receptor deficiency.

Authors:  Payam Tabarsi; Majid Marjani; Nahal Mansouri; Parisa Farnia; Stephanie Boisson-Dupuis; Jacinta Bustamante; Laurent Abel; Parisa Adimi; Jean-Laurent Casanova; Davood Mansouri
Journal:  J Clin Immunol       Date:  2011-04-13       Impact factor: 8.317

2.  The impact of diabetes on tuberculosis treatment outcomes: a systematic review.

Authors:  Meghan A Baker; Anthony D Harries; Christie Y Jeon; Jessica E Hart; Anil Kapur; Knut Lönnroth; Salah-Eddine Ottmani; Sunali D Goonesekera; Megan B Murray
Journal:  BMC Med       Date:  2011-07-01       Impact factor: 8.775

3.  Prognostic factors in patients with miliary tuberculosis.

Authors:  Kentaro Wakamatsu; Nobuhiko Nagata; Hiroyuki Kumazoe; Satosi Honjyo; Makiko Hara; Aiko Nagaoka; Naotaka Noda; Kouji Okamura; Kenji Kawatoko; Mizuko Ose; Erika Yamada; Takashi Akasaki; Sanae Maki; Shinji Ise; Miiru Izumi; Masayuki Kawasaki
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2018-07-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.